Updates are available Correction dated 2021-03-11
Click to view Correction: https://doi.org/10.1038/s42003-021-01894-9
-
Authors
Wang, Zhen
Maluenda, Jérôme
Giraut, Laurène
Vieille, Thibault
Lefevre, Andréas https://orcid.org/0000-0003-3417-0887
Salthouse, David
Radou, Gaël
Moulinas, Rémi
Astete, Sandra
D’Avezac, Pol
Smith, Geoff
André, Charles https://orcid.org/0000-0002-5879-0530
Allemand, Jean-François https://orcid.org/0000-0001-7496-0977
Bensimon, David
Croquette, Vincent
Ouellet, Jimmy
Hamilton, Gordon https://orcid.org/0000-0002-7110-0071
-
Funding
Funding for this research was provided by:
EC | Eurostars (9830)
Agence Nationale de la Recherche (ANR-15-CE12-0015)
EC | Horizon 2020 Framework Programme (829965)
- License Information
-
More Information
Article History
Received: 20 June 2020
Accepted: 28 December 2020
First Online: 29 January 2021
Change Date: 27 February 2021
Change Type: Update
Change Details: A Correction to this paper has been published: https://doi.org/10.1038/s42003-021-01894-9.
Change Date: 11 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s42003-021-01894-9
Competing interests
: J.M., Z.W., L.G., A.L., T.V., G.R., P.D’A., D.S., S.A.M., R.M. G.S., C.A., and J.O. are employees of the company Depixus SAS, which holds exclusive licenses from France’s Centre National de la Recherche Scientifique (CNRS) for the use of the magnetic tweezers for sequencing and epigenetic detection. G.H. is the President (CEO) of Depixus SAS. G.H., V.C., D.B., and J.F.A. are shareholders in Depixus SAS.
